The University of Chicago Header Logo

Connection

Christopher M. Gomez to Dose-Response Relationship, Drug

Back to Details
This is a "connection" page, showing publications Christopher M. Gomez has written about Dose-Response Relationship, Drug.
Christopher M. Gomez
Connection Strength
0.127
Dose-Response Relationship, Drug
  1. Targeting the CACNA1A IRES as a Treatment for Spinocerebellar Ataxia Type 6. Cerebellum. 2018 02; 17(1):72-77.
    View in: PubMed
    Score: 0.114
  2. Antioxidant use in Friedreich ataxia. J Neurol Sci. 2008 Apr 15; 267(1-2):174-6.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.